Skip to content
PICO Portalanswers from OpenAlex

Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy

PaperCitations, authors & open-access status

Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy is a paper indexed in PICO Portal from OpenAlex.

How many citations does Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy have?

PICO Portalcitation count

Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy has 610 citations in the OpenAlex counts PICO Portal stores.

When was Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy published?

PICO Portalyear

Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy has 2022 year in the PICO Portal index.

What is the open-access status of Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy?

PICO Portaloa status

Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy has hybrid oa status in the PICO Portal index.

What is the DOI of Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy?

PICO Portaldoi

The DOI for Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy is on the source record.

What is the PMID of Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy?

PICO Portalpmid

The PMID for Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy is on the source record.

What is the OpenAlex record for Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy?

PICO Portalopenalex

The OpenAlex for Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial